Probiotics synergized with conventional regimen in managing parkinson’s disease

HIGHLIGHTS

• who: Hairong Sun from the Trial design and subject recruitment A three-month double-blind RCT was performed and the experimental processes were shown in Fig1a. All recruited patients received the pharmacological regimen (Benserazide and dopamine agonists, the dosage determined by severity of PD and physical condition of patients, supplementary Table, ) at the beginning of the trial (June , to June, ) in three hospitals (Weihai Municipal Hospital, Liaocheng People`s Hospital, and The First Affiliated Hospital of Jinzhou Medical University). Criteria for inclusion: (1) male or female were diagnosed according to the Published in partnership with the Parkinson . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.